Discover the challenges of treating resistant vaginal thrush and the rise of non-albicans Candida species. Learn about new ...

A change in policy may be helping to drive a rise in treatment-resistant vaginal thrush, amid significant yearly increases in ...

Vaginal thrush is common, with three in every four women of reproductive age likely to be affected. But fungal infections are ...

A change in policy may be helping to drive a rise in treatment-resistant vaginal thrush, amid  significant yearly increases in the prevalence of fungal infections caused by fungal Candida species, ...

Effective from January 1, 2001, standard fluconazole prophylaxis for all VLBW ... The Unit's policy on empiric antibiotic use, particularly cephalosporin use, did not vary during the study period.

Candida species, particularly C. albicans and non-albicans Candida species such as C. glabrata, are the most prevalent pathogenic fungi. Azoles, especially fluconazole, are widely used therapeutic ...

The latter presentation is particularly important, as it is associated with high mortality and a prompt treatment with fungicidal agents is recommended.